References
- Salavastru CM, Chosidow O, Boffa MJ, et al. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31(8):1–2. doi: 10.1111/jdv.14351.
- Rosumeck S, Nast A, Dressler C. Evaluation of ivermectin vs permethrin for treating scabies-summary of a cochrane review. JAMA Dermatol. 2019;155(6):730–732. doi: 10.1001/jamadermatol.2019.0279.
- Sunderkötter C, Aebischer A, Neufeld M, et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019;17(1):15–23. doi: 10.1111/ddg.13706.
- Mang R, Kremer A, Lehmann P, et al. Skabies – klinische Therapieresistenz auf Permethrin: Fallbeschreibungen und eine kritische Auseinandersetzung mit den aktuellen Therapieempfehlungen. Hautarzt. 2021;72(7):595–599. doi: 10.1007/s00105-021-04783-8.
- Meyersburg D, Kaiser A, Bauer JW. Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study. J Dermatolog Treat. 2022;33(2):774–777. doi: 10.1080/09546634.2020.1774489.
- Yürekli A. Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on sarcoptes scabiei from patients with resistant scabies. Dermatol Ther. 2022;35:e15260.
- Mayer KE, Biedermann T, Posch C. European scabies challenge: what about permethrin-resistant mites? J Eur Acad Dermatol Venereol. 2022;36(9):e712–e713. doi: 10.1111/jdv.18181.
- Veraldi S, Schianchi R, Silvio M, et al. Pseudoresistance to permethrin in scabies. J Infect Dev Ctries. 2023;17(5):713–715. (in press). doi: 10.3855/jidc.17750.
- Veraldi S, De Micheli P, Schianchi R, et al. A new treatment regimen with per- methrin in scabies. G Ital Dermatol Venereol. 2018;153:491–493.
- Amerio P, Capizzi R, Milani M. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. Permethrin Cream. Eur J Dermatol. 2003;13:69–71.
- Micali G, Lacarrubba F, Tedeschi A. Videodermatoscopy enhances the ability to monitor efficacy of scabies treatment and allows optimal timing of drug application. J Eur Acad Dermatol Venereol. 2004;18(2):153–154. doi: 10.1111/j.1468-3083.2004.00858.x.
- Biele M, Campori G, Colombo R, et al. Efficacy and tolerability of a new syner- gized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della Scabbia in Ambiente Carcerario). J Eur Acad Dermatol Venereol. 2006;20(6):717–720. doi: 10.1111/j.1468-3083.2006.01623.x.